For ataxin-2, the disease protein in SCA 2, mutant fragment constructs were shown to exhibit an aggregate formation potential in vitro [30], but further studies revealed a decreased cytotoxicity of N-terminally truncated mutant ataxin-2 compared to the full-length protein [31]. This evidence concerns the gene ATXN2 and spinocerebellar ataxia type 2.